AI in Healthcare & Science · AI in Clinical Trials

How Is AI Used to Recruit Patients for Clinical Trials?

AI is used in clinical trial recruitment mainly to scan electronic health records and other patient data to identify individuals who may match a trial's eligibility criteria, helping researchers find suitable candidates faster than manual chart review, though eligibility and enrollment still require human clinical review and patient consent.

Medical disclaimer

This page is for general educational purposes only and is not medical advice. It does not replace a consultation with a licensed physician, pharmacist, or other qualified health provider. Always talk to your own care team before starting, stopping, or changing any medication or supplement.

Key takeaways

AI tools can analyze large volumes of electronic health record data to flag patients whose medical history may match specific trial eligibility criteria.
This can significantly reduce the time researchers and clinical staff spend manually reviewing charts to identify potential candidates.
Identifying a potential match with AI is a first step; enrollment still requires clinical confirmation of eligibility and informed patient consent.
AI-assisted recruitment has also been explored as a way to help identify diverse patient populations for trials, addressing longstanding recruitment challenges.
Privacy and data-use safeguards apply to how patient health information is used in these recruitment tools, similar to other uses of protected health data.

Turning a Slow Manual Process Into a Faster One

Recruiting the right patients for a clinical trial has traditionally been a slow, labor-intensive process, often involving clinical staff manually reviewing patient charts against a trial’s specific eligibility criteria — factors like diagnosis, disease stage, prior treatments, and various exclusion criteria. This manual approach is time-consuming and can be a significant bottleneck in getting a trial fully enrolled and underway. AI tools have been increasingly applied to this problem by analyzing structured data within electronic health records at scale, comparing patterns across a large patient population against a trial’s defined criteria to flag individuals who may be a good match, far faster than a human reviewing charts one at a time could manage.

This use of AI is fundamentally a matching and flagging function rather than a decision-making one. The tool surfaces potential candidates based on data patterns; it doesn’t independently determine who ultimately gets enrolled.

Every patient flagged by an AI recruitment tool as a potential match still needs to go through confirmation by clinical trial staff, who verify the details against the full context of a patient’s actual medical situation — something that isn’t always fully captured in structured health record data. Beyond that clinical confirmation step, no patient can be enrolled in a clinical trial without their voluntary, informed consent, a well-established ethical and legal requirement in clinical research that AI tools don’t change. AI can meaningfully speed up the process of finding potential candidates, but it doesn’t remove these essential human steps from the recruitment pipeline.

A Tool for Addressing Diversity Gaps, Too

Beyond simple efficiency, AI-assisted recruitment has also been explored as a way to help address a longstanding challenge in clinical research: many trials have historically struggled to enroll a patient population that’s diverse and broadly representative. Because AI tools can potentially scan across a wider and more varied set of health systems and patient records than manual outreach efforts typically reach, some researchers have used these tools as part of broader efforts to identify potentially eligible patients from a more diverse range of backgrounds and healthcare settings. This is one piece of a larger, multi-factor effort to improve trial diversity, not a complete solution on its own.

Bottom Line

AI is primarily used in clinical trial recruitment to scan large volumes of patient health record data and flag individuals who may match a trial’s eligibility criteria, which can meaningfully speed up an otherwise slow manual process — though clinical confirmation and voluntary patient consent remain required steps before anyone is actually enrolled.

Go deeper

What role does AI play in determining Medicaid or SNAP eligibility?

Important caveats

AI-flagged candidates still require confirmation from clinical staff and voluntary informed consent from the patient before enrollment.
The accuracy of AI-based matching depends on the completeness and quality of the underlying health record data being analyzed.

Frequently asked questions

Does AI decide who gets enrolled in a clinical trial?

No. AI tools are generally used to help identify potential candidates based on matching data patterns to eligibility criteria, but actual enrollment decisions still require confirmation by clinical trial staff and require the patient's voluntary, informed consent — AI does not make enrollment decisions on its own.

Can AI help make clinical trials more diverse?

AI-based recruitment tools have been explored partly as a way to help identify a broader and more diverse pool of potentially eligible patients across various healthcare settings, which can support efforts to address longstanding underrepresentation of certain populations in clinical research, though achieving this in practice also depends on many other structural factors beyond just identification.

What data do AI recruitment tools typically analyze?

These tools generally analyze structured data from electronic health records, such as diagnosis codes, lab results, and medication history, comparing patterns in this existing clinical data against a specific trial's defined eligibility criteria to flag potential matches for further human review.

Sources

[1]National Institutes of Health — National Institutes of Health
[2]U.S. Food and Drug Administration — U.S. Food and Drug Administration

Written by Editorial Team

Last updated July 25, 2026

Get one well-sourced answer a week

No spam. Unsubscribe anytime.